Healthcare -
Biotechnology - NASDAQ - US
$ 1.055
-4.09 %
$ 55.6 M
Market Cap
-0.36
P/E
ALXO - CAPITAL EXPENDITURES
Capital Expenditures ALXO - ALX Oncology Holdings Inc.
-1.27 M
LAST VALUE
49.13%
2 YEAR CAGR
-14.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR